Theresa Bak-Thomsen serves as Vice President, Research at Hemab, bringing 15 years of expertise in early drug discovery. In her current role, Theresa leads Hemab’s research initiatives with the research team, driving innovation and the new pipeline initiatives. With a career that includes leadership and project management roles at Novo Nordisk, Theresa has demonstrated a keen ability to direct research teams and complex projects in the early research phase. Theresa brings technological experience from leading antibody and proteins technology departments in Denmark and US with a variety of antibody platforms for antibody discovery and screening, research projects with diverse MoA profiles and within different therapeutic areas. Theresa holds a Ph.D. in Immunology from the University of Southern Denmark.